The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FDG-PET based dose escalated adjuvant tomotherapy (image-guided intensity-modulated radiotherapy) utilizing 4D-CT planning  for high-risk adrenocortical carcinoma (ACC): A case study.
Ujjal Mallick
No relevant relationships to disclose
S Ramamurty
No relevant relationships to disclose
Ruth Elizabeth Carr
No relevant relationships to disclose
Nick Willis
No relevant relationships to disclose
S Ball
No relevant relationships to disclose
R BLISS
No relevant relationships to disclose
Judith H. Mott
No relevant relationships to disclose
John B. Wilsdon
No relevant relationships to disclose
S Johnson
No relevant relationships to disclose